-
Publication Venue For
-
Wnt signaling in bone, kidney, intestine, and adipose tissue and interorgan interaction in aging..
1442:48-60.
2019
-
Are low-carbohydrate diets safe in diabetic and nondiabetic chronic kidney disease?
2019
-
Comparative effectiveness clinical trials to advance treatment of myasthenia gravis..
1413:69-75.
2018
-
Developing treatment guidelines for myasthenia gravis..
1412:95-101.
2018
-
Disease drivers of aging..
1386:45-68.
2016
-
Personalized and targeted therapy of esophageal squamous cell carcinoma: an update..
1381:66-73.
2016
-
Tear gas: an epidemiological and mechanistic reassessment..
1378:96-107.
2016
-
Effects of a block in cysteine catabolism on energy balance and fat metabolism in mice..
1363:99-115.
2016
-
One-carbon metabolism and epigenetics: understanding the specificity..
1363:91-98.
2016
-
New functions and signaling mechanisms for the class of adhesion G protein-coupled receptors..
1333:43-64.
2014
-
How copper traverses cellular membranes through the mammalian copper transporter 1, Ctr1..
1314:32-41.
2014
-
Introduction to Human Disorders of Copper Metabolism..
1314:v-vi.
2014
-
The neuroethology of friendship..
1316:1-17.
2014
-
Leveraging paraprofessionals and family strengths to improve coverage and penetration of nutrition and early child development services..
1308:162-171.
2014
-
Cellular origins and molecular mechanisms of Barrett's esophagus and esophageal adenocarcinoma..
1300:187-199.
2013
-
Application of combined omics platforms to accelerate biomedical discovery in diabesity..
1287:1-16.
2013
-
Design of the efficacy of prednisone in the treatment of ocular myasthenia (EPITOME) trial..
1275:17-22.
2012
-
Patient registries: useful tools for clinical research in myasthenia gravis..
1274:107-113.
2012
-
Brain stimulation in neurology and psychiatry: perspectives on an evolving field..
1265:vii-x.
2012
-
Increasing the validity of experimental models for depression..
1265:36-45.
2012
-
The ethics of research on deep brain stimulation for depression: decisional capacity and therapeutic misconception..
1265:69-79.
2012
-
Mouse models for studying genetic influences on factors determining smoking cessation success in humans..
1248:39-70.
2012
-
New and emerging disease modifying therapies for multiple sclerosis..
1247:117-137.
2012
-
Advancing drug discovery for schizophrenia..
1236:30-43.
2011
-
Alcohol research: past, present, and future..
1216:1-23.
2011
-
Potential mechanisms for reduced delivery of nitric oxide to peripheral tissues in diabetes mellitus..
1203:101-106.
2010
-
Transient receptor potential vanilloid 4: The sixth sense of the musculoskeletal system?.
1192:404-409.
2010
-
B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer..
1183:38-57.
2010
-
Antidote-controlled antithrombotic therapy targeting factor IXa and von Willebrand factor..
1175:61-70.
2009
-
Chemoreception scientists gather under the Florida sun: The 31st Annual Association for Chemoreception Sciences meeting..
1170 Suppl 1:1-11.
2009
-
Does meditation enhance cognition and brain plasticity?.
1172:63-69.
2009
-
Trafficking of mammalian chemosensory receptors by receptor-transporting proteins..
1170:153-156.
2009
-
The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration..
1147:61-69.
2008
-
Gastrin-releasing peptide, immune responses, and lung disease..
1144:136-147.
2008
-
Molecular mechanisms of TRPV4-mediated neural signaling..
1144:42-52.
2008
-
Parathyroid hormone-related protein regulates glioma-associated oncogene transcriptional activation: lessons learned from bone development and cartilage neoplasia..
1144:36-41.
2008
-
ADHD and smoking: from genes to brain to behavior..
1141:131-147.
2008
-
Disrupting nicotine reinforcement: from cigarette to brain..
1141:233-256.
2008
-
Functional Assessment of the Efficacy of Oxygen Free Radical Scavengers in the "No-Reflow" Phenomenon in Skeletal Muscle..
723:418-419.
1994